PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10265488

Microcomputer basics, Part IV: Using microcomputers in pathology.

E N Siguel
View original source ↗Export metadata ↓

Abstract

Microcomputers are invading every aspect of life including the practice of pathology. This last in a series of articles is designed to help neophytes make effective use of these new tools. This article describes how microcomputers can be used in pathology and provides guidelines for deciding what processes are worth computerizing and for selecting software. No specific program is recommended.

Explore related subjects

ComputersDecision MakingHospital DepartmentsHumansInformation SystemsManagement Information SystemsMicrocomputersPathology Department, HospitalJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E N Siguel. 1984. Microcomputer basics, Part IV: Using microcomputers in pathology.. https://pubmed.ncbi.nlm.nih.gov/10265488/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Avatars in space.

Explore the source record for details and available documents.

Computers↗
PubMed2000

Structure-based inhibitor design.

Time and costs associated with the discovery of new drugs have been significantly reduced by enzyme structure-based approaches to the discovery of new chemotherapeutic agents. However, fundamental components of the overall approach continue to rely on technologies which, by their nature, involve relatively random processes (i.e., combinatorial chemistry and high-throughput screening). Thus, the efficiency of the drug discovery process potentially could be further improved through better use of structural information. In this regard, three-dimensional structures of enzymes are now being solved at high resolution and/or in conformations that provide data that should be more useful for inhibitor design or discovery. Scientists are beginning to appreciate the importance of water as a possible competitor of inhibitors for binding to target enzymes. New computational algorithms are improving the efficiency of identifying flexible inhibitors from among the large numbers of compounds in chemical databases. Also, tools of molecular genetics together with structures of target enzymes are likely to be used more frequently in dealing with the development of resistance to novel chemotherapeutic agents. Instead of detailing success stories in structure-based drug discovery, the following article considers how future efforts to discover or design new drugs may increasingly rely on information about molecular targets and less on data acquired via approaches involving random methodologies.

Computers↗